Optomed Oyj

Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras.

Bravura’s role as an overall communications advisor:

PRE-IPO

  • Clarifying the equity story

IPO

  • Marketing brochure and materials structure and content
  • IPO marketing campaign planning and implementation
  • Investor web page structure and content
  • Planning the social media campaign
  • Assisting with the retail presentation and the Q&A document

POST-IPO

  • Optomed’s communications strategy

 

IPO and listing on Nasdaq Helsinki Oy’s official list 22 November-2 December 2019

  • The IPO consisted of a public offering in Finland and Sweden as well as of private placement for Finnish and international institutional investors
  • In the IPO, Optomed received over 2,300 new owners, and the company’s shares were subscribed by Finnish and international institutional investors and private investors in Finland and Sweden
  • Subscription price EUR 4.50/share
  • Trading on Nasdaq Helsinki Oy’s official list commenced on 5 December 2019
Read Optomed's IPO marketing brochure here (in Finnish)

The goal of our IPO was to support our growth strategy and increase market awareness of Optomed and the solution we offer in the prevention of blinding eye diseases. During the listing, Bravura took care of the planning and implementation of the communications, anticipating the needs of our team with solid IPO experience. Of particular value to Optomed as the IPO project progressed was the fact that Bravura was well familiar with our story, reacting agilely to communications needs and clarifying our communications opportunities. I can recommend Bravura as a competent advisor and a reliable partner in demanding communications tasks for IPO projects.”

Seppo Kopsala, CEO
Optomed Oyj

Additional information

Pauliina Tennilä

Senior Advisor, partner

+358 40 570 5530
pauliina.tennila@bravura.fi